To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
GTCR backs Jefferson Gregory of King Pharmaceuticals
The Chicago-based private equity house is putting up to $200 million behind Gregory’s vision of a new pharmaceutical company serving a niche market.
